Cadila Healthcare informs about press release

11 Sep 2018 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives tentative approval from the USFDA for Sitagliptin Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

892.75 16.40 (1.87%)
20-Mar-2026 13:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.25
Dr. Reddys Lab 1298.60
Cipla 1258.20
Zydus Lifesciences 892.75
Lupin 2320.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×